Market Research Blog – Page 2143 – New Product Development

Acetyls Market Poised for Growth: Capitalize on the Demand in Polymer Production

The market for acetyls is anticipated to grow at a moderate rate of 5.3% CAGR to reach USD 27,657.60 million in 2023. The market is expected to grow to USD 46,355.30 million by 2033.

The increasing demand for acetyl in numerous end-use sectors, including pharmaceutical, furniture, and oil & gas, together with strong research & development in these areas, are likely to spur market expansion for acetyls.

Request Your Sample Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-1499

Accelerating Production of Paints and Coatings for Market Ascendancy

Acetyls are frequently used as a chelating agent during coatings manufacturing in the paints and coatings industry. These include acetic acid, acetic anhydride, vinyl acetate monomer (VAM), ethylene acetate, and more. Acetyls are used in paints and coatings to speed up drying and prevent corrosion. The output of paints and coatings is expected to rise globally, fueling industry expansion.

Igniting the Growth and Innovation in the Pharmaceutical Industry

Acetyls are largely used to manufacture pharmaceutical medications to improve drug delivery. Antibiotics, vitamins, and other pharmaceutical items are mostly produced using it. In the upcoming years, the market expansion is anticipated to be driven by the rapidly expanding worldwide pharmaceutical industry.

Tackling Raw Material Price Volatility for Sustainable Expansion

Crude oil produces some materials needed to make Acetyl goods. As a result, changes in the price of crude oil could impede market expansion. The unstable and erratic cost of raw materials may constrain market expansion.

Regional Outlook

With a significant acetyls market share, Asia Pacific dominated the market globally. China is anticipated to be the region’s top acetyl consumer. Some key drivers for the acetyls industry include rising demand from the paints and coatings sector, growing adhesive used in the furniture and construction sectors, and expansion in the textile and packaging sectors. Acetyls are in high demand due to the massive chemical industry in Asia Pacific economies. Such factors are anticipated to boost the market during the projected period.

Ask for Report Customization: https://www.futuremarketinsights.com/customization-available/rep-gb-1499

Key Takeaways

The United States might increase its acetyls market share by 24.1% between 2023 and 2033.
Between 2023 and 2033, Germany may hold 14.4% of the acetyls industry.
Japan’s share of the acetyls industry could reach 3.1% between 2023 and 2033.
Australia to hold a 1.7% share of the acetyls market from 2023 to 2033.
During the forecast period, China’s acetyls business to expand at a CAGR of 5.3%.
From 2023 to 2033, the United Kingdom acetyls industry is likely to register at a 3.6% CAGR.
Through 2033, the Indian acetyls market to record a CAGR of 5.9%.
The acetic acid segment of the product type category is predicted to have a market share of 23.9% by 2033.
The pharmaceuticals segment to hold a market share of 38.4% in the end-user category between 2023 and 2033.

Competitive Landscape

Due to the various acetyls players fighting for market share, there is fierce rivalry in the Acetyls industry. Product quality, pricing tactics, technology breakthroughs, and client connections are important variables that affect competition. To maintain a competitive edge in this fast-paced industry, businesses must constantly innovate and set themselves apart.

Prominent Players of Acetyls Market

V.
BP plc
Eastman Chemical Company
Celanese Corporation
Wacker Chemie AG
Daicel Corporation
The Dow Chemical Company

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-1499

Key Segments

By Product Type:

Acetic Acid
Acetic Anhydride
Vinyl Acetate
Formaldehyde
Ethylene Acetate
Others

By End-use Industry:

Food & Beverages
Oil & Gas
Pharmaceutical
Paints, Inks & Waxes & Coatings
Furniture
Others

By Region:

North America
Latin America
Asia Pacific
The Middle East and Africa
Europe

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of ~400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Concrete Floor Coatings Market Projected to Reach USD 5.16 Billion by 2023 with a CAGR of 5.4% | FMI Reports

In 2022, the global concrete floor coatings market was valued at USD 4.95 billion, projected to reach USD 5.16 billion by 2023 and USD 8.74 billion by 2033, boasting a steady CAGR of 5.4% over the decade.

Future Market Insights identifies increased funding for green building initiatives worldwide as the key driver of market growth. Green buildings prioritize eco-friendly, lightweight materials to optimize water, energy, and other resources. The long-lasting, environmentally safe, and VOC-free nature of concrete floor coatings contributes significantly to market expansion, especially in North America and the Asia Pacific region, driven by burgeoning business, infrastructure, and educational institutions.

Powder-based coatings are gaining traction due to their eco-friendly composition, devoid of solvents and VOC emissions, thus reducing air pollution. Their compliance with stringent environmental regulations further propels their market adoption.

Epoxy, polyaspartic, and polyurethane are the primary materials used globally for concrete floor coatings. These materials encompass various product types such as water-based, solvent-borne, and solid-based epoxy coatings, as well as water-based, solvent-borne, moisture-cure, and solids-based polyurethane coatings. The versatility and performance of these coatings, coupled with increasing environmental awareness, are poised to drive market revenues from 2023 to 2033.

Request Your Sample and Stay Ahead with Our Insightful Report!
https://www.futuremarketinsights.com/reports/sample/rep-gb-11744

Market Dynamics :

The global demand for concrete floor coatings is being propelled by a combination of factors, including a burgeoning population and rapid industrialization driving the need for robust infrastructure. Governments worldwide are actively encouraging investment in construction and infrastructure projects to meet these growing demands, thus providing a significant impetus to the concrete floor coatings market.
Epoxy coatings, renowned for their non-volatile nature and high durability, are witnessing increased adoption, further bolstering the growth trajectory of the concrete floor coatings market. Their versatility allows for a wide range of applications, catering to both indoor and outdoor requirements in residential settings, ensuring a consistent and sustainable supply of the product.
Moreover, ongoing research and development endeavors aimed at enhancing the performance and efficiency of concrete floor coatings are anticipated to further stimulate market demand. However, regulatory measures concerning the use of volatile organic compound (VOC) solvents in these coatings may pose challenges to market growth. Nevertheless, the overall outlook for the concrete floor coatings market remains promising, fueled by the continuous evolution and innovation within the industry.

Future Outlook

In the foreseeable future, Asia-Pacific is poised to maintain its leading position in the consumption of concrete floor coatings, driven by rapid infrastructure developments and substantial investments in countries like China, India, and Indonesia. The region’s dynamic construction landscape, propelled by urbanization and industrialization, will sustain its dominance in the global market.
Similarly, Middle Eastern countries such as Saudi Arabia and the UAE will continue to command a significant share in the global concrete floor coatings market, propelled by ongoing construction activities and infrastructural projects.
In North America and Europe, increasing trends in renovation and remodeling activities within the residential sector will be key drivers of demand growth for concrete floor coatings. The emphasis on improving and modernizing existing structures will stimulate market expansion in these regions.
However, Africa is expected to witness relatively slower growth due to limited technological advancements and infrastructure development compared to other regions. Despite this, gradual improvements in infrastructure and urbanization initiatives may lead to modest growth opportunities in the African market for concrete floor coatings in the coming years.

Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights!
https://www.futuremarketinsights.com/checkout/11744

Concrete Floor Coatings Market: Key Participants

Akzo Nobel
ARDEX ENDURA
Asian Paints
Axalta Coating System
BASF SE
Behr Process Corporation
Cameleon Coatings and Paint Manufacturers
CBH Coatings
DAW SE
Dulux
Durall Floor Coatings
Elite Crete Systems
Epmar Corporation

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Heavy Duty Pump Market worth USD 25.7 billion by 2034

The heavy duty pump market is estimated to be worth USD 16.2 billion in 2024 and is projected to be valued at USD 25.7 billion in 2034. Between 2024 and 2034, the industry is expected to register a growth rate of 4.7%. The continuous growth of industries such as manufacturing, mining, and oil and gas serves as a major catalyst for the heavy-duty pump market. These expanding sectors necessitate dependable and high-capacity pump solutions to sustain and optimize their operations, resulting in a heightened and sustained demand for heavy-duty pumps.

Increasing investments in infrastructure development projects, encompassing the construction of bridges, dams, and transportation networks, are driving a surge in demand for heavy-duty pumps. These initiatives frequently require robust pumping solutions to address critical tasks, including dewatering, concrete pumping, and efficient water transfer. Growing apprehensions regarding water scarcity and a heightened focus on effective water management solutions are propelling the demand for heavy-duty pumps. This increased need is particularly evident in critical applications such as wastewater treatment, desalination, and water distribution.

Get Exclusive Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-18869

Advancements in pump technologies, marked by enhancements in efficiency, reliability, and durability, are key drivers of market growth. The integration of smart and automated features further enhances the attractiveness of heavy-duty pumps across diverse industries. Digitalization is transforming the heavy-duty pump sector, with the implementation of digital twins, automation, and data analytics for optimized performance, predictive analytics, and streamlined operations.

Key Takeaways from the Market Report

From 2019 to 2023, the heavy duty pump market expanded at a CAGR of 6.4%.
Based on application, the food processing segment is expected to rise at a CAGR of 4.1% from 2024 to 2034.
The heavy duty pump demand in China is predicted to grow at a CAGR of 5.2% through 2034.
In the United States, the heavy-duty pump industry is estimated to register a CAGR of 5.1% from 2024 to 2034.
The United Kingdom is projected to expand by a value CAGR of 6.2% between 2024 to 2034.
The heavy duty pump market in Japan is anticipated to record a CAGR of 5.5% during 2034.Top of Form

Competitive Landscape

Companies are heavily investing in R&D activities to enhance their heavy-duty pump technologies. Many companies are engaging in strategic collaborations with other industry players, technology partners, or research institutions. These collaborations aim to combine expertise, share resources, and accelerate the development of cutting-edge heavy-duty pump solutions.

Ebara Corporation is a leading global provider of pumps and related technologies. Ebara consistently engages in research and development to enhance pump efficiency and reliability. The company also focuses on expanding its global market presence through strategic initiatives.
Grundfos is a prominent pump manufacturer with a global presence. Grundfos is committed to sustainability and efficiency in pump solutions. The company focuses on incorporating smart technologies and environmental considerations into its products.

Get Full Report Now: https://www.futuremarketinsights.com/checkout/18869

Global Atrophic Vaginitis Treatment Market Poised for Remarkable Growth, Projected to Reach USD 6 Billion by 2033

The latest report from Future Market Insights sheds light on a promising growth trajectory for the global atrophic vaginitis treatment market, forecasting a robust compound annual growth rate (CAGR) of 8% from 2023 to 2033. Anticipated to expand from a valuation of USD 2.78 billion in 2023 to a substantial USD 6 billion by 2033, stakeholders are enthusiastic about the potential advances and broader adoption of effective treatments to meet the increasing demand.

Atrophic vaginitis, a condition predominantly affecting postmenopausal women, manifests symptoms such as vaginal dryness, itching, and painful intercourse. According to a report by the National Institutes of Health, approximately 50% of women experience vaginal discomfort post-menopause, with 10-40% diagnosed with atrophic vaginitis. This underscores the significant patient population in need of effective and sustainable treatment options.

Get Sample Copy of Latest Reports: https://www.futuremarketinsights.com/reports/sample/rep-gb-16831

Key factors driving the growth of the atrophic vaginitis treatment market include:

Increasing prevalence of atrophic vaginitis among postmenopausal women.
Rising awareness about the importance of women’s health and well-being.
Technological advancements in treatment modalities and drug delivery systems.
Initiatives by governments and healthcare organizations to improve access to healthcare services for women.

With a burgeoning market and evolving treatment landscape, stakeholders across the healthcare spectrum are poised to capitalize on emerging opportunities and drive innovation in atrophic vaginitis treatment.

Key Takeaways from the Market Study:

The global Atrophic vaginitis treatment market is expected to grow with an 8% CAGR during 2023 to 2033.
By therapy type, Estrogen based therapy are expected to hold 53% of the market share in 2023 for Atrophic vaginitis treatment market.
North America is expected to possess 48% market share for Atrophic vaginitis treatment market in 2023.
Europe Atrophic vaginitis treatment market size is expected to possess 43% market share in 2023.

“The atrophic vaginitis treatment market is revolutionizing women’s health by providing effective solutions to a common condition that affects millions of women worldwide. With the increasing prevalence of the condition, the market is expected to grow significantly in the coming years. Despite the challenges faced by the industry” states an FMI analyst

Request Customization Available: https://www.futuremarketinsights.com/customization-available/rep-gb-16831

Competitive Landscape:

Key players in the atrophic vaginitis treatment are Shionogi, Duchesnay, Hormos Medical, QuatRx Pharmaceuticals, Pantarhei Bioscience, Mithra Pharmaceuticals, AMAG Pharmaceuticals, Bayer HealthCare Pharmaceuticals Inc, Theramex, Endoceutics, Inc.

Shionogi is a pharmaceutical company that has developed a treatment for atrophic vaginitis called Intrarosa (prasterone). Intrarosa is a vaginal insert that contains the hormone dehydroepiandrosterone (DHEA), which is converted into estrogen in the body.
Bayer HealthCare Pharmaceuticals Inc, a key player in the atrophic vaginitis treatment market is focusing on developing treatments for the ailment by researching and investing in developing therapies.

Key Segments Profiled in the Atrophic Vaginitis Treatment Industry Survey:

Diagnosis:

Pelvic exam
Urine test
Acid balance test

Treatment:

Vaginal moisturizers
Water-based lubricants

Therapy Type:

Estrogen based drugs
Non-estrogen based drugs

Distribution Channel:

Hospital Pharmacy
Online Pharmacy
Retail Pharmacy

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

A Comprehensive Full Report: https://www.futuremarketinsights.com/checkout/16831

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Dairy Alternatives Market Set to USD 46,832.6 Million by 2034, Driven by Health and Lifestyle Shifts

The dairy alternative market refers to the sector of the food industry that provides plant-based alternatives to traditional dairy products like milk, cheese, yogurt, and ice cream. These alternatives are typically made from sources such as nuts (e.g., almonds, cashews), soybeans, coconuts, oats, rice, and hemp.

The global dairy alternatives market is poised for remarkable growth, projected to double its value to US$ 46,832.6 million by 2034, according to a recent market analysis. The market, currently valued at US$ 23,082 million in 2024, is expected to rise at a robust CAGR of 7.3% from 2024 to 2034.

Tap into Market Opportunities and Stay Ahead of Competitors – Get Your Sample Report Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-4852

Factors driving the growth of the dairy alternative market include:

Rising awareness of lactose intolerance and dairy allergies: Many individuals are unable to consume dairy products due to lactose intolerance or allergies to dairy proteins. Dairy alternatives offer a solution for these consumers.
Increasing demand for plant-based products: Growing concerns about health, environmental sustainability, and animal welfare have led to a rise in demand for plant-based food and beverages, including dairy alternatives.
Changing dietary preferences: Consumers are increasingly seeking out vegetarian, vegan, and flexitarian diets, which involve reducing or eliminating animal products. Dairy alternatives provide options that align with these dietary preferences.
Innovation and product development: Food manufacturers are continuously developing new and improved dairy alternative products, offering a wide variety of flavors, textures, and formulations to cater to different consumer preferences.
Retail expansion and accessibility: Dairy alternatives are now widely available in grocery stores, supermarkets, health food stores, and online retailers, making them more accessible to consumers across various demographics.

Key Market Highlights

The growing health consciousness among consumers drives demand for dairy alternatives with lower cholesterol and lesser saturated fats.
The rising cases of lactose intolerance stimulate sales of dairy alternatives such as soy milk, almond milk, rice milk, etc.
The trend toward veganism and adopting plant-based diets is fueling growth in the market. Dairy alternatives are considered a healthier option as they are rich in essential vitamins and minerals.

“Consumers are inclined toward the adoption of nutrient-rich dairy alternatives due to rising concerns related to the environment and sustainability. The market is expected to grow over the forecast period as awareness about plant-based food products is rising,” – Nandini Roy Choudhury, Client Partner at Future Market Insights

Key Takeaways from the Market Study

The dairy alternative market is projected to rise at a CAGR of 7.3% from 2024 to 2034.
The demand for dairy alternatives is expected to reach US$ 46,832.6 million by 2034.
The market grew at a CAGR of 7.0% during the historical period.
The soy segment is set to lead the market, holding a share of 48.2% in 2024.
The B2C segment commands a share of 90.8% of the market by distribution channel in 2024.
The market in Germany is projected to grow rapidly at a CAGR of 8.8% over the forecast period.
The market in the United States is expected to rise at a CAGR of 4.3% through 2034.
The market in India is expected to record a CAGR of 6.8% through 2034.
The market in China is anticipated to increase at a CAGR of 3.5% over the forecast period.

Embrace Smarter Choices With Our Methodology-Derived Insights: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-4852

Competition Analysis

The dairy alternative market is highly competitive. Several players are vying for a larger market share. Key companies are focusing on the development of lactose-free, low-fat dairy alternatives, which attract health-conscious customers. They are emphasizing innovation to expand their market reach.

New players can easily enter the market as complex technologies are not involved in the production of dairy alternatives. They can capitalize on this opportunity to enhance their market presence. Kat players in the market include The Hain Celestial Group, Inc., SunOpta Inc., Danone, Oatly, Vitasoy International Holdings Limited, Daiya Foods Inc., Melt Organic, Living Harvest Foods Inc., Ripple Foods, Earth’s Own Food Company Inc., etc.

Conclusion:

The dairy alternatives market is undergoing significant transformation driven by shifting consumer preferences, health consciousness, and sustainability concerns. As the market continues to evolve, opportunities abound for innovative product development and strategic partnerships to meet the diverse needs of consumers worldwide.

For More Information: Get in touch with our analysts to discover more about growth opportunities in the Dairy Alternative Market. Customize your report by selecting specific countries or regions and save up to 30%.

Global Treatment-Resistant Hypertension Management Market Poised for Remarkable Growth to Reach USD 159.41 Million by 2033

The global treatment-resistant hypertension management market is set to witness substantial growth in the coming years, according to forecasts released by FMI. Projections indicate a significant expansion from USD 43 million in 2023 to a staggering USD 159.41 million by 2033. This impressive surge reflects a compound annual growth rate (CAGR) of 14%, marking a notable acceleration from the 11% CAGR observed between 2018 and 2022.

Treatment-resistant hypertension, characterized by high blood pressure persisting despite the concurrent use of three or more antihypertensive medications, presents a pressing healthcare challenge globally. The condition not only poses severe health risks, including heightened chances of cardiovascular events and end-organ damage but also entails significant management complexities for healthcare providers.

Sample Report Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-16829

With the prevalence of treatment-resistant hypertension on the rise, the demand for innovative therapeutic approaches and advanced management strategies is intensifying. Healthcare stakeholders are increasingly focusing on research and development initiatives aimed at addressing the unmet needs of patients grappling with TRH.

As the TRH management market continues its trajectory of robust growth, healthcare organizations, pharmaceutical companies, and research institutions are poised to play pivotal roles in driving innovation, fostering collaboration, and ultimately enhancing patient outcomes.

The considerable growth projected in the TRH management market can be attributed to several key factors:

Increasing Prevalence: The number of individuals diagnosed with hypertension is on the rise globally, thereby increasing the population of patients who potentially develop treatment-resistant forms of the condition.
Enhanced Awareness: There is a growing recognition of the risks associated with uncontrolled hypertension, which has heightened the demand for more effective management solutions.
Technological and Pharmacological Advancements: Innovations in medical technology and new pharmacological developments have led to the introduction of novel treatment options, expanding the market further.

The surge in research and development activities around TRH management is a testament to the urgent need for innovative and effective treatments that can address the complexities of this condition. Industry stakeholders are increasingly focused on developing strategies that can deliver better health outcomes and improve the quality of life for those affected by this challenging form of hypertension.

As the TRH management market continues to evolve, it holds significant potential for healthcare providers, patients, and medical technology firms specializing in hypertension and cardiovascular care. The next decade is likely to witness the introduction of more advanced and patient-centric solutions that will redefine how treatment-resistant hypertension is managed across the globe.

Key Takeaways from the Market Study:

From 2018 to 2022, the Treatment-Resistant Hypertension Management market grew at a CAGR of 11%.
The global Treatment-Resistant Hypertension Management market is expected to grow with a 14% CAGR during 2023 to 2033.
As of 2033, the Treatment-Resistant Hypertension Management Market is expected to reach USD 159.41 Million.
According to the FMI analysis, the hospitals segment accounts for the largest market share.
North America is expected to possess 40% market share for the Treatment-Resistant Hypertension Management market.
The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Treatment-Resistant Hypertension Management.” says an FMI analyst

Customization with Our Report: https://www.futuremarketinsights.com/customization-available/rep-gb-16829

Market Competition:

Key players in the market include companies such as Competition Deep Dive, Janssen Biotech, Quantum Genomics SA, CinCor Pharma, Ionis Pharmaceuticals, Vifor Pharma, KBP Biosciences, Abbott, Kona Medical, Inc., Medtronic along with healthcare providers and technology companies among other global players.

The findings of a phase II trial, conducted by a researcher from Queen Mary University of London in collaboration with colleagues at CinCor Pharma, USA, indicate that a novel drug named Baxdrostat can effectively decrease high blood pressure (hypertension) in patients who may not respond to existing treatments for the condition. Baxdrostat functions by hindering the body’s production of aldosterone, a hormone that governs the salt levels in the body. The drug successfully reduced the levels of aldosterone in the blood and urine. The study demonstrated that Baxdrostat resulted in a considerable decrease in blood pressure among patients who exhibit resistance to standard medications for hypertension, which is attributed, in part, to excessive production of the aldosterone hormone.

More Insights Available:

FMI, in its new offering, presents an unbiased analysis of the global Treatment-Resistant Hypertension Management market, presenting historical analysis from 2018 to 2022 and forecast statistics for the period of 2023 to 2033.

The study reveals essential insights on the basis of Distribution Channel, Treatment & Region.

Key Segments Profiled in the Treatment-Resistant Hypertension Management Industry Survey

Treatment:

Diuretic therapy
Combination therapy
Mineralocorticoid receptor antagonists

Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

A Full Report Overview: https://www.futuremarketinsights.com/checkout/16829

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Polyglycolic Acid Market on a Trajectory for Explosive Growth, Projected to Reach USD 13 Billion by 2033, with a CAGR of 10% | FMI Reports

The global polyglycolic acid (PGA) market is anticipated to witness a remarkable double-digit Compound Annual Growth Rate (CAGR) of 10%, reaching a market value of approximately USD 13 billion. PGA serves various purposes across industries due to its versatile properties. It is extensively utilized as a filament in 3D printing owing to its ease of extrusion, high strength, and thermal stability. Additionally, PGA finds applications in consumer goods like packaging materials and disposable products, thanks to its biodegradable nature. One of its significant advantages is its biocompatibility, making it safe for medical use in products such as sutures and wound dressings. PGA’s absorbable nature makes it particularly suitable for medical applications where removal is necessary over time. With its robustness, flexibility, and cost-effectiveness, PGA serves diverse sectors including medical, agriculture, 3D printing, and consumer goods.

Get Ahead with Our Report: Request Your Sample Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-11743

Market Dynamics

The fiber form of polyglycolic acid is poised to drive the overall polyglycolic acid market forward, primarily due to heightened demand from the medical industry. This demand surge is attributed to the use of fiber form polyglycolic acid in the production of absorbable surgical sutures, which are extensively utilized across various medical domains including gynecology, obstetrics, ophthalmology, orthopedics, and urology.
Additionally, the escalating consumption of processed and packaged foods such as ready-to-eat meals, frozen foods, snacks, and cake mixes is expected to propel the need for flexible packaging solutions. This, in turn, is anticipated to bolster the growth of the polyglycolic acid market, as it finds applications in the packaging industry along with agriculture, electronics, transportation, and textiles.
Despite these positive outlooks, certain limitations may hinder the global polyglycolic acid market’s growth trajectory. Polyglycolic acid exhibits a relatively low glass transition temperature, rendering it unsuitable for high-temperature applications. Moreover, it is comparatively more brittle than ABS in 3D prototyping, posing challenges to its widespread adoption.

Future Outlook :

In countries like Saudi Arabia, China, Japan, India, and Germany, the increasing demand from oil & gas industries for biodegradable polyglycolic acid, particularly for applications like shopping bags and disposable cutlery, is expected to fuel regional market growth. Additionally, the rising trend of packaged food consumption in North America, particularly in Mexico, Canada, and the US, is projected to drive the demand for polyglycolic acid in packaging materials. Moreover, the presence of an aging population in North America, leading to a higher number of orthopedic, cardiac, and hysterectomy surgeries, is anticipated to further boost the use of polyglycolic acid in medical applications.
Furthermore, Europe is likely to witness significant growth in the polyglycolic acid market due to stringent government regulations promoting the use of biodegradable products. These regulations are expected to create a favorable environment for the adoption of polyglycolic acid across various industries, further driving market growth.
Overall, the increasing awareness regarding environmental sustainability and the growing demand for biodegradable materials across different sectors are poised to sustain the growth momentum of the polyglycolic acid market in the future.

Drive Your Business Growth Strategy: Purchase the Report for Key Insights!
https://www.futuremarketinsights.com/checkout/11743

Polyglycolic Acid Market: Market participants

Huizhou Foryou Medical Devices Co., Ltd. (China)
Kureha Corporation (Japan)
Corbion (Netherland)
Teleflex Incorporated (US)
BMG Incorporated (Japan)
Shenzhen Polymtek Biomaterial Co., (China)

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Global Neovascular Age-Related Macular Degeneration Treatment Market Expected to Surge at 5% CAGR by 2033

According to the latest market research report by Future Market Insights, the global neovascular age-related macular degeneration treatment market is poised for substantial growth, projected at a robust Compound Annual Growth Rate (CAGR) of 5% from 2023 to 2033. The market, valued at USD 3 billion in 2023, is anticipated to reach USD 4.89 billion by the end of 2033.

Neovascular age-related macular degeneration, a prevalent concern predominantly among individuals aged 50 and above, poses a significant threat to global eye health. This condition, a leading cause of vision loss within the demographic, disrupts the macula, the crucial central region of the retina responsible for precise and detailed vision. The manifestation of nAMD involves the abnormal growth of blood vessels beneath the retina, leading to fluid and blood leakage, consequently damaging the macula and impairing visual function.

Get the Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-16817

North America and Europe are the largest markets for nAMD treatment, with the United States, Germany, and the United Kingdom being the major contributors. The strong healthcare infrastructure, increasing patient awareness, and availability of advanced treatment options are the key factors driving growth in these regions. However, the report notes that the Asia Pacific region is expected to experience significant growth in the coming years, driven by increasing prevalence of nAMD, expanding healthcare infrastructure, and introduction of new treatments.

Key Takeaways from the Market Study:

From 2018 to 2022, the neovascular age-related macular degeneration treatment market grew at a CAGR of 3.5%.
The global neovascular age-related macular degeneration treatment market is expected to grow with a 5% CAGR during 2023 to 2033.
As of 2033, the Neovascular Age-related Macular Degeneration Treatment Market is expected to reach USD 4.89 Billion.
According to the FMI analysis, the Wet AMD segment accounts for the largest market share.
North America is expected to possess 40% market share for the Neovascular Age-related Macular Degeneration Treatment market.
The East & South Asia market is predicted to increase significantly throughout the forecast period, with a share of 20% during the forecast period.

“A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering Neovascular Age-related Macular Degeneration Treatment.” says an FMI analyst

Request Customization Available: https://www.futuremarketinsights.com/customization-available/rep-gb-16817

Market Competition:

Key players in the market include companies such as Competition Deep Dive, Beckman Coulter Inc., Baxter International Inc., ChemoCentryx Inc., Dimerix Ltd, Medtronic PLC, Pfizer Inc., Mylan N.V., Amgen Inc., AstraZeneca plc along with healthcare providers and technology companies among other global players.

Susvimo™ (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant was granted FDA approval on October 22, 2021. This approval is for the treatment of wet or neovascular age-related macular degeneration (AMD) in individuals who have previously responded to at least two anti-vascular endothelial growth factor (VEGF) injections. Wet AMD is a leading cause of blindness in people aged 60 and older and affects approximately 1.1 million people in the United States.

Key Segments Profiled in the Neovascular Age-related Macular Degeneration Treatment Industry Survey:

Drug Type:

Ranibizumab
Aflibercept
Bevacizumab
Brolucizumab
Faricimab

Disease Type:

Dry AMD
Wet AMD

Age Group:

Less than 60
Between 60 to 80
More than 80

Gender:

Male
Female

Stage of Disease:

Early-stage AMD
Intermediate AMD
Late-stage AMD

Distribution Channel:

Hospital Pharmacy
Specialty Pharmacy
Online Pharmacy

Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa

Get Full Report Now: https://www.futuremarketinsights.com/checkout/16817

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:

Sales of Saffron Global Market Strategic Growth & Forecast Analysis – 2024-2034

The saffron market refers to the global trade and consumption of saffron, a highly prized spice derived from the flower crocus sativus. Saffron is known for its vibrant red-orange color, distinctive flavor, and various applications in culinary, medicinal, cosmetic, and other industries.

The global saffron market is poised for substantial growth, with an estimated value of US$ 337.9 million by 2024, projected to soar to US$ 687.8 million by 2034, reflecting a robust CAGR of 7.4%. Saffron, derived from the flower crocus sativus, is renowned for its vibrant red-orange color and unique flavor, making it a prized ingredient in various cuisines worldwide.

Tap into Market Opportunities and Stay Ahead of Competitors – Get Your Sample Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-1840

The saffron market encompasses the production, distribution, and consumption of saffron products, including saffron threads, powdered saffron, liquid saffron, and saffron derivatives. It involves key players such as saffron growers, manufacturers, distributors, retailers, and consumers.

Factors driving the saffron market include increasing consumer demand for natural and exotic ingredients, rising awareness of saffron’s health benefits, growing interest in diverse cuisines, and expanding applications in pharmaceuticals and cosmetics. Additionally, technological advancements, global trade networks, and online platforms have made saffron more accessible to consumers worldwide, fueling market growth.

Overall, the saffron market represents a dynamic and evolving landscape, characterized by innovation, product diversification, and efforts to ensure quality and authenticity in saffron products.

Rising Demand for Saffron Threads and Health Benefits Propel Growth

End-users predominantly favor saffron threads over powdered and liquid forms, attributing to their authenticity and versatility. In 2024, saffron threads are expected to capture a significant revenue share of 78.7%, driven by their superior flavor profile and ease of use in culinary applications.

Moreover, the surge in demand for saffron is fueled by its potential health benefits, including antioxidant and anti-inflammatory properties. Consumers are increasingly drawn to saffron-infused products for their purported mood-enhancing and wellness properties, further boosting market growth.

Key Takeaways from the Saffron Report:

The global market for saffron is expected to reach a valuation of US$ 687.8 million by 2034.
Global demand for saffron will likely rise at 7.4% CAGR between 2024 and 2034.
Based on form, the saffron threads segment is set to total US$ 526.1 million in 2034.
By end-use application, the food & beverages processing industry is expected to grow at 5.1% CAGR through 2034.
North America will likely hold a value share of 20.5% in the global market by 2034.
The United Kingdom market is estimated to witness a value CAGR of 6.1% through 2034.
Saffron sales in India are projected to total US$ 105.2 million by 2034.

Innovative Product Formats and Applications Open New Avenues

Manufacturers are actively exploring new product formats and applications for saffron, such as saffron-infused oils, teas, and beauty products. The growing usage of saffron in pharmaceuticals and cosmetics is also contributing to market expansion, driven by its antioxidant and anti-depressant properties.

Global Trade Expansion and Quality Assurance Drive Market Accessibility

Technological advancements and improved global trade networks have made saffron more accessible to consumers worldwide. E-commerce platforms provide a convenient avenue for purchasing saffron, while manufacturers focus on quality assurance measures to ensure product authenticity and credibility.

Saffron Market: A Landscape of Innovation and Expansion

Top manufacturers are expanding their product lines to include a wider range of saffron products, leveraging online channels to reach a broader audience. Notable developments include Tata Consumer Products’ introduction of Grade 1 Kashmiri saffron under the Himalayan brand, featuring AI-enabled QR codes for authenticity verification.

Conclusion

The global saffron market presents lucrative opportunities driven by increasing consumer demand for high-quality, natural ingredients. With a focus on innovation, product diversification, and quality assurance, manufacturers are poised to capitalize on the growing popularity of saffron across various industries, from culinary to pharmaceuticals and cosmetics.

For More Information: Get in touch with our analysts to discover more about growth opportunities in the Saffron Market. Customize your report by selecting specific countries or regions and save up to 30%.

Global Crohn’s Disease (CD) Treatment Market Projected to Reach USD 17.80 Billion by 2033

The global crohn’s disease (CD) treatment market is poised for substantial growth, projected to reach a value of approximately USD 17.80 billion by the end of 2033, up from USD 11.68 billion at the end of 2023. This revelation comes from a comprehensive report by Future Market Insights, showcasing a steady compound annual growth rate (CAGR) of 4.3% over the next decade.

The increasing incidence of Crohn’s disease and ulcerative colitis worldwide is the primary catalyst for this upward trajectory. As awareness and understanding of these conditions continue to spread, the demand for effective treatment options intensifies, fostering robust market expansion.

Request for a Sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-16809

One of the key driving forces behind this growth is the advancement in treatment modalities, notably the use of biologics such as adalimumab, infliximab, certolizumab, and golimumab. These innovative therapies offer enhanced efficacy and represent a significant leap forward in managing Crohn’s disease and ulcerative colitis.

The report underscores the pivotal role played by biologics in shaping the landscape of Crohn’s disease treatment, providing healthcare professionals and patients with more targeted and personalized approaches to care.

“As the global burden of Crohn’s disease and ulcerative colitis continues to rise, there is an urgent need for effective treatment options,” said FMI. “The projected growth of the Crohn’s disease treatment market reflects not only the increasing prevalence of these conditions but also the strides made in therapeutic innovation. This presents an opportunity for stakeholders to collaborate and drive further advancements in patient care.”

With the global Crohn’s disease treatment market poised for significant expansion, stakeholders across the healthcare spectrum are encouraged to prioritize research, innovation, and collaboration to meet the evolving needs of patients worldwide.

Key Takeaways from the Market Study:

The Crohn’s disease treatment market expanded historically between 2018 and 2022 at a CAGR of 3.2%.
More than $11.2 billion is presently spent on treating Crohn’s disease globally.
Immunomodulators are predicted to lead the medication type sector in 2023 with a 53% revenue share.
The hospital pharmacy sector by distribution channel will maintain the second-largest segment during the anticipated period, with a global market share of 27.3% in 2023.
From 2023 to 2033, the North American region is expected to expand at a constant CAGR of 4.9%.
From 2023 to 2033, the Asia Pacific Crohn’s Disease Treatment Market is anticipated to expand at a stable CAGR of 3.6%.

“The increasing prevalence of ulcerative colitis and Crohn’s disease along with innovative pipeline of biological therapies and medications are expected to accelerate the growth during the forecast period,” comments a Future Market Insights analyst.

Customization with Our Report: https://www.futuremarketinsights.com/customization-available/rep-gb-16809

Competitive Landscape:

Some of the top players in the global intraocular lymphoma disease market are:

Abbvie Inc.
Celgene Corporation
Genetech
Johnson & Johnson
Pfizer
Prometheus Laboratories Inc. (Nestle)
Salix Pharmaceuticals Inc.
Takeda’s Pharmaceutical Ltd
Janssen Pharmaceuticals
Biogen
AstraZeneca

Some of the recent developments in this domain are:

In 2022, AbbVie said that SKYRIZI® (risankizumab-rzaa) has received FDA approval to be used in the management of moderately to highly active Crohn’s disease. The interleukin-23 (IL-23) inhibitor SKYRIZI binds to the p19 component of IL-23 to specifically inhibit it. A variety of chronic immune-mediated disorders, including Crohn’s disease, are suspected to be related to IL-23, a cytokine implicated in inflammatory processes.
Tiziana Life Sciences, a biotechnology firm that enables breakthrough immunotherapies through innovative modes of monoclonal antibody administration, announced the start of a Phase 1b clinical study in 2022 to test foralumab enteric-coated capsules orally delivered in people who have mild to moderate Crohn’s Disease (CD). A unique method of inducing an anti-inflammatory immune reaction by site-targeted immunomodulation in the intestine is oral administration of foralumab.

Key Segments Covered in the Crohn’s Disease Treatment Market Report:

By Drug Type:

Antibiotics
Amino Salicylates
Corticosteroids
Immunomodulators
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa

A Full Report Analysis: https://www.futuremarketinsights.com/checkout/16809

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us: